TOURISE Announces USD 113BN in Portfolio Investments to Accelerate the Future of Tourism
11.11.2025 18:42:00 CET | Business Wire | Press Release
TOURISE, the bold global platform shaping a new horizon for tourism, announced today that it has catalyzed investment portfolios totaling USD 113BN at the inaugural TOURISE Summit in Riyadh. The milestone reflects TOURISE’s mission to unlock high‑value deal flow by convening public and private sector leaders across tourism, technology, investment, and sustainability to set a shared roadmap for the next 50 years of global tourism.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251111666032/en/
His Excellency Ahmed Al Khateeb, Saudi Arabia's Minister of Tourism and Chairman of TOURISE announces USD 113 BN of investment portfolios catalyzed at the inaugural TOURISE Summit.
The announced portfolio investments span the full breadth of the visitor economy: luxury retail, next‑generation hotel accommodation, large‑scale integrated, experience‑led developments, wellness, destination and lifestyle offerings, talent development, and AI‑powered platforms. Collectively, these commitments set a new standard for what’s possible, and what’s required, to meet future tourism needs and redesign the traveler journey.
Just some of the international and local companies who announced their portfolios as part of the USD 113BN include: Melia Hotels, BWH Hotels, GOCO Hospitality, Cenomi, Radisson, Earth Hotels, Delonix & Ocean Link, AlFozan Holding, Al Kathiri Holding, Alothaim, and Knowledge Economic City.
By combining hard infrastructure with human capital, and fusing data, design, and hospitality, these investments will unlock new value across the tourism ecosystem, create new job opportunities, and deliver unforgettable, purpose‑driven experiences at scale. Above all, many were Saudi focused, cementing the Kingdom’s international competitiveness and desirability as a leading global travel destination, where culture, innovation, and world‑class service come together, and signal to partners and investors that this is where the next era of tourism growth is to be built.
Investment ushers in the next chapter of the global tourism economy
His Excellency Ahmed Al-Khateeb, Minister of Tourism and Chairman of the Board of TOURISE, commented “TOURISE has been the catalyst that brings investors, policymakers, and innovators to the same table, turning vision into bankable partnerships and high‑impact deals. Together, we’re redefining the entire traveler economy—powered by AI, built on destination and experience excellence, and designed so growth and opportunity extend across the ecosystem.”
Today’s announcement advances TOURISE’s founding purpose: to unite decision‑makers and disruptors across the public and private spheres to accelerate transformative partnerships and convert ambition into action through high‑impact dealmaking. With the announcement of such unprecedented levels in the tourism ecosystem, it highlights how TOURISE brings the right people together at the right time to drive outcomes that will reshape how the world travels, connects, and grows.
About TOURISE
TOURISE is the world’s premier platform shaping a new horizon for global tourism.
Powered by the Saudi Ministry of Tourism, the inaugural TOURISE Summit will take place 11–13, November 2025 in Riyadh. TOURISE will convene visionaries from government, business, investment, and academia to unlock the innovations that will drive holistic impact initiatives and transformative deals that will reset the industry and build a tourism sector that is sustainable, equitable, and future-focused.
Physically exclusive and digitally inclusive, TOURISE will ensure broad global participation while providing targeted access to visionaries shaping the future of global tourism. Following the Summit, TOURISE will extend as a year-round platform where bold ideas become real-world solutions.
This is where the next 50 years of tourism are shaped. Together, we are unstoppable.
For more information about TOURISE, visit www.TOURISE.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20251111666032/en/
Contacts
media@tourise.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Huawei, LG Electronics and Nokia Named as Founder Licensors of New Sisvel POS Pool1.4.2026 12:17:00 CEST | Press Release
Three world-class innovators are the founder licensors of the new Point of Sale (POS) patent pool, covering 2G to 5G technology, which Sisvel has launched today. Huawei, LG Electronics and Nokia have made their standard essential patents (SEPs) reading on cellularly connected POS devices available through the programme, so simplifying access to the increasingly ubiquitous technology. Early participation incentives for licensors to join the pool are available until mid-May. Other cellular patent owners not currently in discussions with Sisvel are encouraged to get in touch. Ranging from handheld card machines to tablet-based registers, POS devices have transformed customer payment processing. Increasingly, they also offer enhanced capabilities such as inventory management, real-time tracking, advanced analytics and automatic re-ordering. Standardised cellular technology is the critical feature that enables POS terminals to function wherever customers are located. The Sisvel POS programm
Mosaic Therapeutics appoints Dr Vince O'Neill, MD, as Head of R&D1.4.2026 11:11:00 CEST | Press Release
Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company developing next-generation, Synergistic Precision combination therapies, today announced the appointment of Dr Vince O’Neill as Head of Research and Development (R&D) to support its next phase of growth. “We are delighted to welcome Vince to the Mosaic leadership team at this pivotal stage of the company’s evolution,”said Thomas Fuchs, CEO, Mosaic Therapeutics.“His deep expertise in targeted oncology drug development and diagnostics will be instrumental as we advance our pipeline to bring transformative therapies to patients in need.” Vince is a board-certified medical oncologist and highly experienced biotechnology executive, bringing over two decades of therapeutic and diagnostic R&D experience within industry to Mosaic Therapeutics, with a track record spanning from IND through to NDA/BLA/MAA approval. Most recently he served at BioXcel Therapeutics as EVP, Head of Product Developme
The AI Summit London Launches Strategic Partnerships with London Business School and General Purpose to Ignite New Era in AI Leadership1.4.2026 09:00:00 CEST | Press Release
The AI Summit London, the conference where commercial AI comes to life, has announced strategic collaborations with London Business School and General Purpose to introduce two dedicated AI Training programmes, taking place ahead of the conference on 9 June. Drawing upon the globally recognised expertise in executive education at the London Business School’s Data Science & AI Initiative (DSAI), the one-day AI Leadership Accelerator is a high-impact session designed to equip senior business leaders with the knowledge and tools to unlock real and profitable value from AI. The DSAI at London Business School helps leaders make sense of AI in a way that goes beyond the hype, focusing on what it really means for their organisations, industries, and competitive positioning. Drawing on rigorous, cross-disciplinary research, DSAI provides clear, evidence-based insights - equipping executives with the perspective needed to make confident, high-stakes decisions. “Through our work we increasingly s
Samsung Research Reveals Over Half of Europeans Admit to Looking at a Stranger's Phone Screen in Public – With Nearly a Quarter Doing so out of Sheer Curiosity1.4.2026 08:00:00 CEST | Press Release
As millions of Europeans2 get ready to enjoy the Easter weekend, new research from Samsung finds Europe’s public spaces have become shared screens: 56% of people say they have accidentally looked at a stranger’s phone, citing public transport as the most likely place to notice someone else’s screen (57%). Nearly one in four Europeans2 (24%) admit to looking at someone else’s phone out of curiosity, exposing a stream of private content from personal photos to bank details. Samsung Electronics surveyed 11,000 Europeans2 to support the launch of the Galaxy S26 Ultra, which introduces a built-in Privacy Display. This new hardware-based technology keeps screen content visible only from the front to protect privacy from side angles, without compromising the viewing experience3. The study further reveals a gap between perceived phone privacy and reality: While 48%* feel their own phone use is private when using it in crowded places, 52%** find it easy to view someone else’s screen in public.
RevolKa Reimagines Antibody Engineering with "RevoAb ® "1.4.2026 06:30:00 CEST | Press Release
RevolKa Ltd. (RevolKa), a venture-backed biotech company providing an advanced AI protein engineering technology platform, called aiProtein®, is pleased to announce the official global launch of RevoAb®, an innovative and quick online service for antibody sequence optimization to solve challenges in physicochemical properties, especially antibodyyields. RevoAb®:The Next-Gen AI Antibody Design Since December 2023, RevolKa has provided an antibody optimization services utilizing aiProtein®. The newly launched RevoAb® is a quick intuitive online antibody sequence optimization service that integrates RevolKa’s core technology—the "Refined Naturalness Framework Engineering". RevoAb® is designed to generate antibody framework sequences optimized for improved physicochemical properties, especially protein expression levels, without trade-off of affinity. This allows researchers worldwide to experience RevolKa’s high-performance antibody design. Key Advantages of RevoAb® Speed: Multiple optimi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom